Manténgase actualizado sobre Omnipod®
El Sistema de Administración de Insulina Automatizado Omnipod 5 es el primer sistema híbrido de asa cerrada (Pod), sin catéter y portátil que se integra con las principales marcas de sensores∞, para sus pacientes con diabetes tipo 1 (DT1) a partir de los 2 años. Regístrese a continuación para recibir las últimas novedades, incluidas las actualizaciones sobre los productos y las innovaciones, y las nuevas compatibilidades de los sensores.
Recursos educativos sobre Omnipod
Eventos educacionales y resultados clínicos
Novedades de Omnipod 5
Formación sobre Omnipod
Manténgase actualizado sobre Omnipod
Rellene el siguiente formulario y le mantendremos informado sobre Omnipod 5; también le avisaremos cuando Omnipod 5 esté disponible en su país.
Intended Purpose as per Instructions for Use for The Omnipod 5 Automated Insulin Delivery System: The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older requiring insulin. The Omnipod 5 System is intended to operate as an automated insulin delivery system when used with compatible Continuous Glucose Monitors (CGM). When in Automated Mode, the Omnipod 5 System is designed to assist people with type 1 diabetes in achieving glycaemic targets set by their healthcare providers. It is intended to modulate (increase, decrease or suspend) insulin delivery to operate within predefined threshold values using current and predicted sensor glucose values to maintain blood glucose at variable target glucose levels, thereby reducing glucose variability. This reduction in variability is intended to lead to a reduction in the frequency, severity, and duration of both hyperglycaemia and hypoglycaemia. The Omnipod 5 System can also operate in a Manual Mode that delivers insulin at set or manually adjusted rates. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with U-100 rapid acting insulin.
Warning: DO NOT start to use the Omnipod® 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over delivery or under-delivery of insulin, which could lead to hypoglycaemia or hyperglycaemia.